For decades, corporate media and elected officials have shown little interest in reporting by incarcerated individuals on the ...

Carfilzomib prevented BCMA degradation, increased target density, and improved CAR T susceptibility by ~26%–28% in vitro, while enhancing xenograft antitumor activity without worsening T-cell ...

A method called "in vivo CAR-T (in vivo CAR-T·intra-body CAR-T)" that directly alters immune cells within the body with a single injection is recently changing the landscape of the cancer treatment ...

2-year-old’s recovery from severed spinal cord shows how surgery can help patients regain movement, even after paralysis ...

In AYAs, the ASH guideline panel recommends pediatric-inspired (asparaginase-containing) regimens for treatment-naïve B-ALL and T-ALL, and blinatumomab for relapsed/refractory B-ALL.

Ameet Patel, MD, concludes by outlining strategies to overcome operational, financial, and payer challenges in delivering advanced multiple myeloma therapies.

Learn more about whether IDEAYA Biosciences, Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

His recovery is uncertain. But Logan Reese’s family is holding on to the small signs — and the hope that his body might still surprise them.

During long infusion and chemo days at WVU Cancer Institute’s Mary Babb Randolph Cancer Center, patients like Judy McNair get free bag lunches delivered by volunteers.

Success is no longer just about prolonging survival, but about enabling patients to live well after cancer, with fewer ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 12:15 PM ESTCompany ParticipantsZachary Roberts ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM ESTCompany ParticipantsSamarth Kulkarni - CEO ...